ATE296304T1 - Immunsuppressive wirkstoffe und verfahren - Google Patents

Immunsuppressive wirkstoffe und verfahren

Info

Publication number
ATE296304T1
ATE296304T1 AT97908794T AT97908794T ATE296304T1 AT E296304 T1 ATE296304 T1 AT E296304T1 AT 97908794 T AT97908794 T AT 97908794T AT 97908794 T AT97908794 T AT 97908794T AT E296304 T1 ATE296304 T1 AT E296304T1
Authority
AT
Austria
Prior art keywords
methods
immunosupressive
ingredients
compounds
immunosuppressive
Prior art date
Application number
AT97908794T
Other languages
German (de)
English (en)
Inventor
You Mao Qi
John H Musser
John M Fidler
Original Assignee
Pharmagenesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmagenesis Inc filed Critical Pharmagenesis Inc
Application granted granted Critical
Publication of ATE296304T1 publication Critical patent/ATE296304T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT97908794T 1996-03-01 1997-02-28 Immunsuppressive wirkstoffe und verfahren ATE296304T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/609,277 US5663335A (en) 1996-03-01 1996-03-01 Immunosuppressive compounds and methods
PCT/US1997/003202 WO1997031921A1 (en) 1996-03-01 1997-02-28 Immunosuppressive compounds and methods

Publications (1)

Publication Number Publication Date
ATE296304T1 true ATE296304T1 (de) 2005-06-15

Family

ID=24440096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97908794T ATE296304T1 (de) 1996-03-01 1997-02-28 Immunsuppressive wirkstoffe und verfahren

Country Status (12)

Country Link
US (1) US5663335A (https=)
EP (1) EP0907652B1 (https=)
JP (1) JP4267697B2 (https=)
CN (1) CN1133637C (https=)
AT (1) ATE296304T1 (https=)
AU (2) AU2125897A (https=)
CA (1) CA2248266C (https=)
DE (1) DE69733353T2 (https=)
DK (1) DK0907652T3 (https=)
ES (1) ES2242214T3 (https=)
PT (1) PT907652E (https=)
WO (2) WO1997031920A1 (https=)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880116A (en) * 1996-12-13 1999-03-09 Neurocal International Use of celastrol to treat alzheimer's disease
US6004999A (en) * 1997-05-23 1999-12-21 Hoechst Marion Roussel, Inc. Triptolide derivatives useful in the treatment of autoimmune diseases
DK0983275T3 (da) * 1997-05-23 2002-12-23 Aventis Pharma Inc Nye triptolidderivater, der er nyttige til behandling af autoimmune sygdomme
US5972998A (en) * 1997-05-23 1999-10-26 Hoechst Marion Roussel, Inc. Triptolide derivatives useful in the treatment of autoimmune diseases
JP2002500647A (ja) * 1997-05-23 2002-01-08 アベンティス・ファーマスーティカルズ・インコーポレイテッド 自己免疫疾患の治療に有用な新規なトリプトリド誘導体
EP1375488B1 (en) * 1998-09-02 2006-08-02 Pharmagenesis, Inc. Triptolide prodrugs having high aqueous solubility
US6548537B1 (en) 1998-09-02 2003-04-15 Pharmagenesis, Inc. Triptolide prodrugs having high aqueous solubility
CA2342901A1 (en) * 1998-09-02 2000-03-09 Pharmagenesis, Inc. Triptolide prodrugs having high aqueous solubility
WO2000045800A2 (en) * 1999-02-02 2000-08-10 K.U. Leuven Research & Development Immunosurpressive effects of pteridine derivatives
US6329148B1 (en) 1999-02-16 2001-12-11 The Board Of Trustees Of The Leland Stanford University Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells
WO2000063212A1 (en) * 1999-04-16 2000-10-26 Chengdu Diao Pharmaceutical Group Company Limited Derivatives of triptolide, and preparation and uses thereof
US7323471B1 (en) * 1999-08-13 2008-01-29 Dor Biopharma, Inc. Topical azathioprine for the treatment of oral autoimmune diseases
US6294546B1 (en) * 1999-08-30 2001-09-25 The Broad Of Trustees Of The Leland Stanford Junior University Uses of diterpenoid triepoxides as an anti-proliferative agent
US6620843B2 (en) * 2001-01-19 2003-09-16 Pharmagenesis Anticancer treatment using triptolide prodrugs
EP1390358A4 (en) * 2001-03-15 2004-06-16 Pharmagenesis Inc AMINO ACID DERIVATIVES OF TRIPTOLIDE COMPOUNDS AS IMMUNOMODULATORS AND ANTICROPHES
EP2468277A1 (en) 2002-05-31 2012-06-27 Pharmagenesis, Inc. Triptolide derivatives for modulation of apoptosis and immunosuppression
CN100398544C (zh) * 2002-09-18 2008-07-02 成都达远药物有限公司 高免疫抑制活性的水溶性雷公藤内酯醇衍生物及其应用
WO2004058246A1 (en) * 2002-12-17 2004-07-15 Pharmagenesis, Inc. Triptolide derivatives as immunomodulator and anticancer agents
CN1223595C (zh) 2002-12-27 2005-10-19 中国科学院上海药物研究所 雷公藤内酯醇衍生物及其应用
US6943259B2 (en) * 2003-02-25 2005-09-13 Pharmagenesis, Inc. Halogenated triptolide derivatives as immunomodulators and anticancer agents
CN100408583C (zh) * 2003-02-25 2008-08-06 美国泛华医药公司 用作免疫调节剂和抗癌药的卤代雷公藤内酯醇衍生物
WO2005062913A2 (en) * 2003-12-24 2005-07-14 Pharmagenesis, Inc. Triplide 5,6-derivatives as immunomodulators and anticancer agents
EP1722806A4 (en) * 2004-02-09 2009-09-16 Pharmagenesis Inc METHOD OF ISOLATING TRIPTOLIDE COMPOUNDS FROM TRIPTERYGIUM WILFORDII
WO2005084365A2 (en) 2004-03-02 2005-09-15 Pharmagenesis, Inc. Triptolide lactone ring derivatives as immunomodulators and anticancer agents
WO2006012204A2 (en) * 2004-06-25 2006-02-02 Pharmagenesis, Inc. Method for treatment of inflammatory disorders using triptolide compounds
WO2006044496A2 (en) 2004-10-13 2006-04-27 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
EP1924548B1 (en) 2005-07-13 2018-03-28 Salvia Sciences, Inc. Ester prodrugs of prostratin and related phorbol compounds
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
US8067632B2 (en) * 2007-07-26 2011-11-29 The Board Of Trustees Of The Leland Stanford Junior University Process to produce prostratin and structural or functional analogs thereof
CN101235041B (zh) * 2007-10-26 2013-05-29 北京美迪克斯生物技术有限公司 四种雷公藤甲素衍生物及其制剂的制备方法
CN104387406A (zh) * 2009-02-05 2015-03-04 药物起源公司 作为抗癌药和免疫调制剂的雷公藤内酯 c-环衍生物
US9150600B2 (en) 2009-05-07 2015-10-06 Regents Of The University Of Minnesota Triptolide prodrugs
DK2427467T3 (en) 2009-05-07 2015-11-09 Univ Minnesota Triptolid prodrugs
CN102286065B (zh) * 2010-06-18 2012-11-14 中国科学院上海药物研究所 松香烷型二萜衍生物、其制备方法和应用
LT3510860T (lt) 2012-08-23 2021-10-25 Senestech, Inc. Žinduolių reprodukcinio pajėgumo sumažinimas
US9670205B2 (en) 2015-03-04 2017-06-06 Gilead Sciences, Inc. Toll like receptor modulator compounds
WO2016205539A1 (en) * 2015-06-16 2016-12-22 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno Non-hormonal male contraceptive agents and methods using same
EP3248981B1 (en) * 2015-10-29 2022-03-09 Hangzhou Weben Pharmaceuticals Inc. C14-hydroxyl esterified amino acid derivatives of triptolide, and preparation method and use thereof
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
AU2017318601B2 (en) 2016-09-02 2020-09-03 Gilead Sciences, Inc. Toll like receptor modulator compounds
CN106890187A (zh) * 2017-02-22 2017-06-27 中山大学附属第三医院 雷公藤甲素及其修饰物在抑制b细胞产生抗体中的应用
CN109021061B (zh) * 2018-09-29 2019-07-12 郭可点 雷公藤甲素靶向前药及其制备方法和应用
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
CN111440185B (zh) * 2020-03-31 2021-05-14 中国农业科学院蜜蜂研究所 一种半抗原及其在检测雷公藤乙素和雷公藤甲素方面的应用
CN115466269A (zh) * 2021-06-11 2022-12-13 复旦大学 一种胆碱碳酸酯类前药及其制备方法和应用
CN114478684B (zh) * 2022-01-21 2023-10-31 南京中医药大学 一类雷公藤甲素前药、其制备方法及其医药用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005108A (en) * 1973-04-03 1977-01-25 Research Corporation Novel anti-leukemic diterpenoid triepoxides
CA1310009C (en) * 1984-03-28 1992-11-10 John Mark Braughler Ester prodrugs of steroids
CN1027371C (zh) * 1989-09-08 1995-01-11 中国医学科学院皮肤病研究所 二萜内酯化合物的合成方法
CN1052860A (zh) * 1989-12-22 1991-07-10 中国医学科学院皮肤病研究所 雷藤氯内酯醇的制备方法及抗生育用途
CN1052861A (zh) * 1989-12-22 1991-07-10 中国医学科学院皮肤病研究所 雷醇内酯的制备方法及抗生育用途
US5430054A (en) * 1989-12-22 1995-07-04 Jiangsu Family Planning Institute Preparation methods of diterpene lactone compounds and application of the same to antifertility
CN1052859A (zh) * 1989-12-22 1991-07-10 中国医学科学院皮肤病研究所 17-羟基雷藤内酯醇及类似物的结构与制备方法
AU7570191A (en) * 1990-03-14 1991-10-10 Board Of Regents, The University Of Texas System Tripterygium wilfordii hook f extracts and components thereof for immunosuppression

Also Published As

Publication number Publication date
CA2248266A1 (en) 1997-09-04
AU712241B2 (en) 1999-11-04
EP0907652B1 (en) 2005-05-25
DK0907652T3 (da) 2005-08-08
ES2242214T3 (es) 2005-11-01
WO1997031920A1 (en) 1997-09-04
JP2001504437A (ja) 2001-04-03
CA2248266C (en) 2007-10-23
CN1133637C (zh) 2004-01-07
HK1019444A1 (en) 2000-02-11
AU2061397A (en) 1997-09-16
EP0907652A1 (en) 1999-04-14
DE69733353T2 (de) 2006-02-02
PT907652E (pt) 2005-08-31
AU2125897A (en) 1997-09-16
WO1997031921A1 (en) 1997-09-04
DE69733353D1 (de) 2005-06-30
US5663335A (en) 1997-09-02
CN1246121A (zh) 2000-03-01
JP4267697B2 (ja) 2009-05-27

Similar Documents

Publication Publication Date Title
ATE296304T1 (de) Immunsuppressive wirkstoffe und verfahren
ATE245145T1 (de) Gut wasserlösliche triptolid-prodrugs
LV12358A (lv) 7-(Aizvietoti)-9-(aizvietoti glicil)-amido-6-demetil-6-deoksitetraciklini
DK0946507T3 (da) Substituerede pyrrolylforbindelser til behandling af inflammation
ES2194106T3 (es) .ompuestos de imidazol
ID16878A (id) Turunan indol yang bermanfaat untuk pengobatan
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
ES2151921T3 (es) Analogo de dolastatina.
TR199801919T2 (xx) Rapamisin t�revlerinin damar hastal�klar� ve yabanc� doku naklinde kullan�m�.
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
DE69729302T2 (de) Illudin analoge verwendet als antitumormittel
DE69720757D1 (de) Pde-iv hemmende 2-cyanoiminoimidazol-derivate
ES2150705T3 (es) Derivados de ester de nitrito esteroideos utiles como farmacos antiinflamatorios.
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
ATE222910T1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
PT983272E (pt) Nova classe de compostos fotoactivos derivados de benzoporfirina
NO981818D0 (no) FremgangsmÕte for Õ mobilisere hematopoetiske stamceller
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
EA199900534A1 (ru) Имидазопиридазины
ES2184761T3 (es) Derivados de taxanos c10 y composiciones farmaceuticas.
DE3873278D1 (de) Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
DK0827505T3 (da) Udvalgte opløselige estere af hydroxylholdige indolocarbazoler
MY116769A (en) Immunosuppressive compounds and methods
ES2101531T3 (es) Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.
ES2165020T3 (es) Monohidrato de famciclovir.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0907652

Country of ref document: EP

REN Ceased due to non-payment of the annual fee